Summary
This Form 8-K filing by Vertex Pharmaceuticals Inc. on April 16, 2009, primarily serves to report the company's financial results for the quarter ended March 31, 2009. The core of this report is the incorporation by reference of a press release (Exhibit 99.1) detailing these results. Investors should refer to this attached press release for specific figures regarding revenue, expenses, net income, and any other operational or financial performance metrics for the first quarter of 2009. While the 8-K itself doesn't provide the detailed financial numbers, it acts as the official notification that these results have been disseminated. The filing also clarifies that the information in the press release is furnished and not deemed 'filed' under Section 18 of the Securities Exchange Act, meaning it doesn't carry the same legal liabilities as formally filed statements, but it is still crucial for understanding the company's performance during the reported period.
Key Highlights
- 1Vertex Pharmaceuticals Inc. filed a Form 8-K on April 16, 2009.
- 2The filing's primary purpose is to report the company's financial results for the quarter ended March 31, 2009.
- 3The detailed financial results are contained within an attached press release (Exhibit 99.1).
- 4Investors are directed to Exhibit 99.1 for specific operational and financial performance data for Q1 2009.
- 5The information furnished in the press release is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- 6The filing confirms the date of the event reported as April 15, 2009.